Global Specialty Enzymes Market to Exceed $4.4 Billion by 2012 According to New Report by Global Industry Analysts Inc.



Enzymes are proteins with highly specialized catalytic functions produced by all living organisms. Enzymes play a major role in various aspects of life and are very important to the existence of life itself. Three fourth of the 'bulk' consumption of enzymes is accounted for the industries of food, starch processing and detergent. Specialty enzymes are used in a host of medical applications and diagnostics, including testing of food products.

Asia-Pacific represents the fastest growing market for specialty enzymes , recording a CAGR of over 9% over the period 2000-2010, as stated by Global Industry Analysts, Inc. Specialty enzymes market (http://www.strategyr.com/Specialty_Enzymes_Market_Report.asp) in the US is estimated at $1.1 billion. In terms of product segments, global specialty medical enzymes market (http://www.strategyr.com/Specialty_Enzymes_Market_Report.asp) is expected to grow at a compounded annual rate of nearly 8.25% over the period 2000-2010. In Europe, demand for specialty enzymes in pharmaceuticals & diagnostics (http://www.strategyr.com/Specialty_Enzymes_Market_Report.asp) is projected to be worth $1.0 billion in 2012.

Protein engineering, gene expression and such advanced technologies aid in selective screening, modification and manufacture of enzymes in large quantities. As such the enzyme market is undergoing a gradual transition from commodity based to proprietary based with specialty enzymes supporting novel applications, and gradually narrowing down the distinction between industrial and specialty enzymes . Many major companies involved in enzyme production are endeavoring through various avant-garde technologies to progress in this direction. Companies ranging from biotechnology to chemicals, and pharmaceuticals are actively researching in this direction.

The report titled "Specialty Enzymes: A Global Strategic Business Report" published by Global Industry Analysts, Inc., provides a review of end-use markets, product overview, product introductions/innovations, and recent industry activity. The study provides market analytics for the period 2000-2015, in value sales for United States, Canada, Japan, Europe, Asia-Pacific, Middle East and Latin America. Product segments discussed include Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes. End-use segments discussed are Pharmaceuticals & Diagnostics and Research/Biotechnology.

Market participants include Advanced Enzymes Technologies, Amano Enzyme, Aureozyme, Biocon, Biozyme Laboratories, Danisco, Genencor, Kinetic Biosystems, Maxygen, Codexis, Novozymes, Seravac Biotech, Specialty Enzymes and Biochemicals and Verenium Corporation.

For more details about this research report, please visit

http://www.strategyr.com/Specialty_Enzymes_Market_Report.asp

About Global Industry Analysts, Inc.

Global Industry Analysts, Inc., (GIA) (http://www.strategyr.com) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of over 60,000 smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.

Telephone 408-528-9966

Fax 408-528-9977

Email press@StrategyR.com

Web Site www.StrategyR.com





Global Specialty Enzymes Market to Exceed $4.4 Billion by 2012 According to New Report by Global Industry Analysts Inc.